Mesoblast Limited (MESO) vs Maravai LifeSciences Holdings, Inc. (MRVI)
Mesoblast Limited and Maravai LifeSciences Holdings, Inc. are both Biotechnology companies. Mesoblast Limited and Maravai LifeSciences Holdings, Inc. are of similar size ($2.0B and $2.0B). Maravai LifeSciences Holdings, Inc. grew revenue faster over the last twelve months: −5.03% against −26.5%. Maravai LifeSciences Holdings, Inc. has the higher net margin (−37.1% vs −1,091.7%) and the lower return on invested capital (−15.8% vs 0.00%). Across the 18 metrics below, Maravai LifeSciences Holdings, Inc. leads on 10 and Mesoblast Limited on 8.
Valuation
Profitability
| Metric | MESO | MRVI | Biotechnology median |
|---|---|---|---|
| Gross margin | (269.72%) | 34.89% | 65.16% |
| Operating margin | (826.28%) | (56.08%) | 0.00% |
| Net margin | (1,091.71%) | (37.07%) | 0.00% |
| Free cash flow margin | 0.00% | (17.17%) | 0.00% |
| Return on equity | 0.00% | (18.79%) | (57.72%) |
| Return on assets | 0.00% | (10.31%) | (49.22%) |
| Return on invested capital | 0.00% | (15.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack